Nan Hui
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Cancer-related molecular mechanisms research
Papers in
-
- Ubiquitin and proteasome pathways 1
- RNA modifications and cancer 1
-
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 detection and testing 1
- Co-authors
- Chengyuan Liang (4 shared papers)Lei Tian (4 shared papers)Han Li (2 shared papers)Yuzhi Liu (2 shared papers)Hong Liu (2 shared papers)Yonghong Tang (1 shared paper)Xiaodong Ren (3 shared papers)Zhenfeng Shi (1 shared paper)
In The Last Decade
Nan Hui
7 papers receiving 231 citations
Peers
Comparison fields: 5 of 69
- Infectious Diseases 66
- Cancer Research 32
- Molecular Biology 97
- Pharmacology 11
- Computational Theory and Mathematics 20
Countries citing papers authored by Nan Hui
This map shows the geographic impact of Nan Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Hui more than expected).
Fields of papers citing papers by Nan Hui
This network shows the impact of papers produced by Nan Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Hui. The network helps show where Nan Hui may publish in the future.
Co-authors
The 25 scholars most cited alongside Nan Hui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 88 | |
| 2 | 2021 | 65 | |
| 3 | 2019 | 35 | |
| 4 | 2021 | 30 | |
| 5 | 2021 | 10 | |
| 6 | 2024 | 6 | |
| 7 | 2025 | 1 |
About Nan Hui
Nan Hui is a scholar working on Molecular Biology, Infectious Diseases, Ocean Engineering, Oncology and Biomaterials, having authored 7 papers that have together received 235 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (1 paper), Ubiquitin and proteasome pathways (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), SARS-CoV-2 detection and testing (1 paper), Lung Cancer Research Studies (1 paper), Polymer Surface Interaction Studies (1 paper), Marine Biology and Environmental Chemistry (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Infectious Diseases (66 citations), Cancer Research (32 citations), Molecular Biology (97 citations), Pharmacology (11 citations) and Computational Theory and Mathematics (20 citations). Nan Hui has collaborated with scholars based in China and Lebanon. Frequent co-authors include Chengyuan Liang, Lei Tian, Han Li, Yuzhi Liu, Hong Liu, Yonghong Tang, Xiaodong Ren, Zhenfeng Shi, Xiaolin Xie and Dezhu Zhang. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Orthopaedic Translation, Gene, Phytomedicine and Materials Today Bio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.